HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Proton beam therapy holds ‘great promise’ at a steep cost
• AMA report card finds health insurance error rates cut in half in 2012
• Cancer center names director
• Center names new director
• Children with Hodgkin’s lymphoma responded to limited radiotherapy
• Harvard professor receives award
• HIV increases risk of HPV detection, cuts clearance rate
• Joint Consensus Statement: Improved workplace wellness programs needed
• NIH presents research award
• Palliative care director named
• Preconditioning regimen had little effect on outcomes in ATL post-transplantation
• Second-generation agents replace ‘miracle drug’ imatinib for first-line CML treatment
• Smoking increased risk for squamous cell carcinoma
• Society elects new president
• Surgeon honored as ACS fellow
• UC San Diego appoints CEO
• University names oncology chief
• Allografting on outpatient basis can decrease GVHD prevalence, severity Guillermo J. Ruiz-Argüelles, MD, FACP, FRCP (Glasg); David Gómez-Almaguer, MD
• Agency grants priority review for prostate cancer drug
• Agency approves colonoscopy prep regimen
• FDA approves everolimus for advanced HER-2–negative breast cancer
• FDA calls for more data on apixaban
• Multiple myeloma drug receives accelerated approval
• A 67-year-old man develops peritoneal carcinomatosis from gastric carcinoma Munir Ghesani, MD, FACNM; Rangaswamy Chintapatla, MD; Michael Thomas Starc, MD; Gabriel Sara, MD
• 5-aminosalicylic acid offered no protection against colorectal cancer
• Aspirin may reduce risk for Barrett’s esophagus
• BCC subtypes varied between biopsy, excision specimens
• Cancer screenings for patients with rheumatoid arthritis comparable to general population
• Cap-assisted colonoscopy more effective than standard method
• Chemotherapy after cancer resection near pancreas may improve survival
• Efficacy of letrozole, anastrozole linked to BMI
• Endoscopy may reduce risk for advanced adenomas, not sessile serrated polyps
• Flexible sigmoidoscopy associated with decrease in colorectal cancer incidence, mortality
• Gene expression test reduced decision to operate on indeterminate nodules
• Hedgehog inhibitor effective in advanced basal cell carcinomas
• HER receptor and ligand protein overexpressed in patients with thymic carcinoma
• High-grade nuclear atypia associated with invasive lung adenocarcinoma, aided diagnosis
• HPV vaccine showing some protective effects for unvaccinated
• HR capabilities affected pain management at inpatient centers
• Increased antioxidant intake may lower risk for pancreatic cancer
• Intervention boosted early antibiotic development for neutropenic patients
• Keyhole limpet hemocyanin inferior to mitomycin for bladder cancer recurrence
• Less iron during pregnancy appears as effective in preventing anemia
• Low-dose radioiodine sufficient for patients with thyroid cancer
• Multiple childhood CT scans increased risk for brain tumors, leukemia
• Negative biopsy margins in SCC, BCC produced different results
• One-fifth of breast-conserving surgeries in England required reoperation
• Overall survival remained poor for patients with Sézary syndrome
• Platelet drug improved blood count in aplastic anemia patients
• Radiotherapy effectively treated facial squamous cell carcinoma
• Researchers complete first genome-wide analysis of aggressive blood cancer
• Tanning bed use increased risk for cutaneous melanoma
• Task force recommends annual CT screening for long-term smokers, lung cancer survivors
• Type 2 diabetes linked to increased risk for blood cancer
• Vismodegib showed adverse events in effectively treating patients with basal cell nevus syndrome
• Young adult patients with cancer lack psychosocial support
• Young women given inadequate information about fertility preservation options
• Zoledronic acid offered no significant survival benefit for patients with stage III NSCLC
• Antiretrovirals failed to raise cancer risk
• Cervical cancer risk in women with HIV similar to those uninfected
• NSABP B-38: Addition of gemcitabine to AC-P failed to improve outcomes in breast cancer
• Pazopanib offered greater quality of life than sunitinib for patients with renal cancer